Cue Biopharma's total assets for Q2 2025 were $40.71M, an increase of 82.92% from the previous quarter. CUE total liabilities were $22.55M for the fiscal quarter, a 43.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.